HHV8-Negative Primary Effusion Lymphoma of B-Cell Lineage: Two Cases and a Comprehensive Review of the Literature [PDF]
Case Reports in Oncological Medicine, 2013 Primary effusion lymphoma (PEL) is a rare extranodal lymphoma that typically presents in a body cavity in the absence of a detectable tumor mass and that occurs predominantly in immunosuppressed individuals.
Neeraj Saini +5 more
doaj +2 more sources
HHV8 and EBV‐negative primary effusion‐based lymphoma: A case report of a new provisional entity and review of literature [PDF]
Clinical Case Reports, 2023 Key Clinical Message HHV8‐ and EBV‐negative primary effusion lymphoma is an extremely rare neoplasm involving body cavities without detectable tumor mass. It usually presents in elderly patients without known immunodeficiency.
Marta Canelo‐Vilaseca +11 more
doaj +2 more sources
VALUTAZIONE VIREMIA HHV8 IN MALATTIE LINFOPROLIFERATIVE HHV8 RELATE
Microbiologia Medica, 2007 -
A. Marus +8 more
doaj +3 more sources
HHV8/EBV Coinfection Lymphoproliferative Disorder: Rare Entity with a Favorable Outcome [PDF]
Case Reports in Hematology, 2017 HHV8/EBV-associated germinotropic lymphoproliferative disorder (GLD) is a challenging diagnosis given its rarity, the particular clinical presentation, and the lack of expression of markers usually used in establishing hematopoietic lineage.
Dhouha Bacha +6 more
doaj +2 more sources
Blood, 2006 It is unclear how the immune response controls human herpesvirus 8 (HHV8; also known as Kaposi sarcoma-associated herpesvirus [KSHV]) replication and thereby prevents Kaposi sarcoma (KS).
Lebbe, C. +9 more
core +3 more sources
Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma. [PDF]
PLoS Pathogens, 2012 The contribution of innate immunity to immunosurveillance of the oncogenic Human Herpes Virus 8 (HHV8) has not been studied in depth. We investigated NK cell phenotype and function in 70 HHV8-infected subjects, either asymptomatic carriers or having ...
Stéphanie Dupuy +7 more
doaj +2 more sources
A Review of KSHV/HHV8-Associated Neoplasms and Related Lymphoproliferative Lesions
LymphaticsThere has been extensive research on the KSHV/HHV8 virus, which has led to a better understanding of viral transmission, pathogenesis, viral-driven lymphoid proliferation, neoplastic transformation, and how we might combat these processes clinically.
Jamie Rigney +3 more
doaj +2 more sources
KSHV/HHV8-Associated Lymphoproliferative Disorders: Lessons Learnt from People Living with HIV
Hemato, 2021 In 1992, Kaposi sarcoma herpesvirus (KSHV/HHV8) was discovered and identified as the causative agent for Kaposi sarcoma. Subsequently, the presence of this virus has been detected in a number of lymphoproliferative disorders in people living with HIV ...
Mark Bower, Antonino Carbone
doaj +2 more sources
HHV8-positive multicentric Castleman’s disease and thrombotic thrombocytopenic purpura among HIV-positive patients [PDF]
European Journal of Case Reports in Internal MedicineCastleman’s disease (CD) and thrombotic thrombocytopenic purpura (TTP) are rare diseases that can affect the general population, especially those with HIV. Owing to their rarity, the association between CD and TTP remains insufficiently understood.
Roxane Pasquer +5 more
doaj +2 more sources
Extracavitary Primary Effusion Lymphoma in an HIV-Negative Patient With Aberrant Immunophenotypic Features. [PDF]
EJHaemeJHaem, Volume 7, Issue 5, October 2026.
Centoducatte GL +3 more
europepmc +2 more sources